Talerman A, Haije W G, Baggerman L
Cancer. 1978 Jan;41(1):272-8. doi: 10.1002/1097-0142(197801)41:1<272::aid-cncr2820410138>3.0.co;2-z.
Serum AFP was determined serially by radioimmunoassay in 13 patients with ovarian germ cell tumors and in one patient with bilateral pure gonadoblastoma. There were 4 patients with pure dysgerminoma, one with pure endodermal sinus tumor (EST) and 8 with mixed germ cell tumors, all containing EST. The patients with dysgerminoma and gonadoblastoma had normal serum AFP at all times. All patients with tumors containing EST had raised serum AFP, although in most cases it was first determined between 1 and 3 weeks after operation and there was no evidence of metastases. Serum AFP became normal 5 to 7 weeks after operation and began to rise when disease recurred. Serum AFP determinations detected presence of recurrent disease long before it became detectable by other methods. Serum CEA was determined serially by radioimmunoassay in 8 of these patients, including 2 who dies with metastases, and was normal on all occasions.
采用放射免疫分析法对13例卵巢生殖细胞肿瘤患者及1例双侧纯性腺母细胞瘤患者的血清甲胎蛋白(AFP)进行了连续检测。其中有4例纯无性细胞瘤患者,1例纯内胚窦瘤(EST)患者以及8例混合性生殖细胞肿瘤患者,所有混合性生殖细胞肿瘤患者均含有EST。无性细胞瘤和性腺母细胞瘤患者的血清AFP一直正常。所有含EST肿瘤的患者血清AFP均升高,不过在大多数情况下,首次检测是在术后1至3周,且无转移证据。术后5至7周血清AFP恢复正常,疾病复发时又开始升高。血清AFP检测在其他方法可检测到复发性疾病之前很久就能检测到其存在。对其中8例患者采用放射免疫分析法连续检测血清癌胚抗原(CEA),包括2例死于转移的患者,其血清CEA在所有检测时均正常。